Product Information
- (2R,3R)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-6-methyl-4H-1-benzopyran-4-one
- 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-6-methyl-, (2R,3R)-
- 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-6-methyl-, (2R-trans)-
- 6-Methyldihydroquercetin
- Flavanone, 3,3′,4′,5,7-pentahydroxy-6-methyl-
Cedeodarin is a potent inhibitor of the protein Dr5 and has been shown to suppress tumor development in animal models. It may also be used for treatment of cancer due to its ability to inhibit the production of inflammatory cytokines such as TNF-related apoptosis-inducing ligand (TRAIL). Cedeodarin has been shown to have anti-cancer properties by inhibiting the growth of cancer cells and inducing cell death. This compound also inhibits xanthine oxidase, which can lead to decreased levels of uric acid in blood.
Cedeodarin is derived from the Indian plant Cephalotaxus drupacea and has a hydroxyl group at position 5 on the indole ring that acts as a pharmacophore. The presence of this functional group makes cedeodarin an inhibitor of xanthine oxidase, which has been shown to inhibit tumor development in animal models. This compound also inhibits toll-like receptor 4 (TLR
Chemical properties
Technical inquiry about: 3D-GBA07639 Cedeodarin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
